People s United Financial Inc. Acquires 575 Shares of HCA Healthcare, Inc. (NYSE:HCA)

People s United Financial Inc. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 44.5% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,867 shares of the company’s stock after buying an additional 575 shares during the quarter. People s United Financial Inc.’s holdings in HCA Healthcare were worth $386,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HCA. State of Alaska Department of Revenue grew its stake in HCA Healthcare by 2.9% in the second quarter. State of Alaska Department of Revenue now owns 50,106 shares of the company’s stock worth $10,358,000 after purchasing an additional 1,406 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its stake in HCA Healthcare by 113.3% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 22,099 shares of the company’s stock worth $4,162,000 after purchasing an additional 11,738 shares in the last quarter. Oppenheimer & Co. Inc. grew its stake in HCA Healthcare by 3.0% in the first quarter. Oppenheimer & Co. Inc. now owns 20,385 shares of the company’s stock worth $3,839,000 after purchasing an additional 589 shares in the last quarter. DAVENPORT & Co LLC bought a new position in HCA Healthcare in the second quarter worth approximately $638,000. Finally, Oppenheimer Asset Management Inc. lifted its holdings in shares of HCA Healthcare by 2.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 7,689 shares of the company’s stock valued at $1,449,000 after purchasing an additional 163 shares during the last quarter. 68.57% of the stock is currently owned by hedge funds and other institutional investors.

In related news, insider Charles J. Hall sold 3,000 shares of the stock in a transaction on Tuesday, July 27th. The shares were sold at an average price of $249.94, for a total transaction of $749,820.00. Following the completion of the sale, the insider now owns 210,140 shares in the company, valued at approximately $52,522,391.60. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,000 shares of the stock in a transaction on Wednesday, July 21st. The stock was sold at an average price of $252.00, for a total transaction of $252,000.00. Following the sale, the senior vice president now owns 15,899 shares of the company’s stock, valued at approximately $4,006,548. The disclosure for this sale can be found here. In the last three months, insiders have sold 59,093 shares of company stock worth $14,778,068. 1.60% of the stock is owned by corporate insiders.

A number of equities analysts recently issued reports on the company. Truist raised their target price on HCA Healthcare from $260.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, July 21st. Credit Suisse Group raised their target price on HCA Healthcare from $222.00 to $267.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 21st. Seaport Res Ptn reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Friday, July 9th. TheStreet downgraded HCA Healthcare from a “b” rating to a “c+” rating in a research report on Tuesday, July 20th. Finally, Barclays reaffirmed a “neutral” rating on shares of HCA Healthcare in a research report on Friday, August 27th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Buy” and an average target price of $241.57.

Shares of NYSE:HCA opened at $258.25 on Thursday. The stock has a market cap of $82.68 billion, a P/E ratio of 17.71, a PEG ratio of 1.38 and a beta of 1.65. The company has a quick ratio of 1.21, a current ratio of 1.45 and a debt-to-equity ratio of 18.06. HCA Healthcare, Inc. has a 52-week low of $114.38 and a 52-week high of $263.92. The business has a fifty day moving average of $248.72 and a two-hundred day moving average of $218.27.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Monday, July 19th. The company reported $4.37 earnings per share for the quarter, topping analysts’ consensus estimates of $3.16 by $1.21. The business had revenue of $14.44 billion during the quarter, compared to analysts’ expectations of $13.61 billion. HCA Healthcare had a return on equity of 234.29% and a net margin of 8.87%. The company’s revenue was up 30.4% compared to the same quarter last year. During the same period in the prior year, the business posted $3.23 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 16.78 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 30th. Investors of record on Thursday, September 16th will be paid a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a yield of 0.74%. The ex-dividend date is Wednesday, September 15th. HCA Healthcare’s payout ratio is 16.54%.

About HCA Healthcare

HCA Healthcare, Inc is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.

Featured Article: How to Trade Using Analysts Ratings

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.